kkleiner writes "A team has launched a crowdsourcing campaign to develop sustainable natural lighting by using a genetically modified version of the flowering plant Arabidopsis. Using the luciferase gene, the enzyme responsible for making fireflies glow, the researchers will design, print, and transform the genes into the target plant. The project, which was recently launched on Kickstarter, has already raised over $100k with over a month left to go."

ananyo writes "Two dangerous things together might make a medicine for one of the hardest cancers to treat. In a mouse model of pancreatic cancer, researchers have shown that bacteria can deliver deadly radiation to tumours — exploiting the immune suppression that normally makes the disease so intractable. The researchers coated the bacterium Listeria monocytogenes with radioactive antibodies and injected the bacterium into mice with pancreatic cancer that had spread to multiple sites. After several doses, the mice that had received the radioactive bacteria had 90% fewer metastases compared with mice that had received saline or radiation alone."

hessian writes with a story at Wired (excerpt below) about a project from Drew Endy of the International Open Facility Advancing Biotechnology, or BIOFAB, to standardize a programming language connecting genetic information from DNA to the cell components that DNA can create. "The BIOFAB project is still in the early stages. Endy and the team are creating the most basic of building blocks — the 'grammar' for the language. Their latest achievement, recently reported in the journal Science, has been to create a way of controlling and amplifying the signals sent from the genome to the cell. Endy compares this process to an old fashioned telegraph. 'If you want to send a telegraph from San Francisco to Los Angeles, the signals would get degraded along the wire,' he says. "At some point, you have to have a relay system that would detect the signals before they completely went to noise and then amplify them back up to keep sending them along their way.""

ananyo writes with this bit about lab grown organs from Nature: "Scientists at Massachusetts General Hospital in Boston have fitted rats with kidneys that were grown in a lab from stripped-down kidney scaffolds. When transplanted, these 'bioengineered' organs starting filtering the rodents' blood and making urine. The team, led by organ-regeneration specialist Harald Ott, started with the kidneys of recently deceased rats and used detergent to strip away the cells, leaving behind the underlying scaffold of connective tissues such as the structural components of blood vessels. They then regenerated the organ by seeding this scaffold with two cell types: human umbilical-vein cells to line the blood vessels, and kidney cells from newborn rats to produce the other tissues that make up the organ (paper)."

An anonymous reader writes "Scientists have discovered a way to convert ordinary skin cells into myelinating cells, or brain cells that have been destroyed in patients with multiple sclerosis, cerebral palsy and other myelin disorders. The research, published in the journal Nature Biotechnology, may now enable 'on demand' production of myelinating cells, which insulate and protect neurons to facilitate the delivery of brain impulses to the rest of the body."

An anonymous reader writes "Monday, the Supreme Court will hear a case on the validity of breast cancer gene patents. The court has a chance to end human gene patents after three decades. From the article: 'Since the 1980s, patent lawyers have been claiming pieces of humanity's genetic code. The United States Patent and Trademark Office has granted thousands of gene patents. The Federal Circuit, the court that hears all patent appeals, has consistently ruled such patents are legal. But the judicial winds have been shifting. The Supreme Court has never ruled on the legality of gene patents. And recently, the Supreme Court has grown increasingly skeptical of the Federal Circuit's patent-friendly jurisprudence. Meanwhile, a growing number of researchers, health care providers, and public interest groups have raised concerns about the harms of gene patents. The American Civil Liberties Union estimates that more than 40 percent of genes are now patented. Those patents have created "patent thickets" that make it difficult for scientists to do genetic research and commercialize their results. Monopolies on genetic testing have raised prices and reduced patient options.'"

Lasrick writes "Derrin Culp of the National Center for Disease Preparedness explores the different levels of scrutiny that scientists in microbiology undergo, when compared to those who work in the nuclear weapons field. His complaint is that, even though America's most notorious biosecurity breach — the 2001 anthrax mailings — was the work of an insider, expert panels have concluded that there is no need for intrusive monitoring of microbiologists engaged in unclassified research."

carmendrahl writes "3-D printers don't build only solid objects anymore. They also build liquid objects, thanks to a research team at the University of Oxford. The group custom crafted a 3-D printer to squirt tiny liquid droplets from its nozzles. The 3-D patterned droplets can mimic biological tissues, such as nerve fibers, and may have potential in tissue engineering applications. An expert not involved with the study is cautious about endorsing the tissue engineering applications because they're not yet demonstrated, but praises the team for extending 3-D printing to new classes of materials."

Last week you had a chance to ask co-founder and CEO of Intellectual Ventures, Nathan Myhrvold, questions before his live Q&A. Below you'll find his answers to a few of the highest rated. Make sure you come back today from 12-12:30pm PDT (3-3:30pm ET, 19:00-19:30 GMT) to ask him whatever you like in real time. We'll have a new story for your questions at that time.

cylonlover writes "Australian scientists have successfully revived and reactivated the genome of an extinct frog. The 'Lazarus Project' team implanted cell nuclei from tissues collected in the 1970s and kept in a conventional deep freezer for 40 years into donor eggs from a distantly-related frog. Some of the eggs spontaneously began to divide and grow to early embryo stage with tests confirming the dividing cells contained genetic material from the extinct frog. The extinct frog in question is the Rheobatrachus silus, one of only two species of gastric-brooding frogs, or Platypus frogs, native to Queensland, Australia. Both species became extinct in the mid-1980s and were unique amongst frog species for the way in which they incubated their offspring."

ananyo writes "The research world's most famous human cell has had its genome decoded, and it's a mess. German researchers this week report the genome sequence of the HeLa cell line, which originates from a deadly cervical tumor taken from a patient named Henrietta Lacks (Slashdot has previously noted a film made about the cells and there's a recent mutli-award winning book on Lacks). Established the same year that Lacks died in 1951, HeLa cells were the first human cells to grow well in the laboratory. The cells have contributed to more than 60,000 research papers, the development of a polio vaccine in the 1950s and, most recently, an international effort to characterize the genome, known as ENCODE. The team's work shows that HeLa cells contain one extra version of most chromosomes, with up to five copies of some, and raises further questions over the widespread use of HeLa cells as models for human cell biology."

Nerval's Lobster writes "Former vice president Al Gore sat down with Wall Street Journal columnist Walt Mossberg at this year's SXSW conference to talk about the future — specifically, what Gore sees as the dangers and opportunities awaiting the planet for the next few years. Gore drilled down into what he referred to as the "stalker economy." The rise of apps such as SnapChat, which allows smartphone users to control how long friends can view messages, is emblematic of people reaching the "gag point" with pervasive recording and surveillance by government and business. "Our democracy has been hacked," Gore also told his audience, referring to the U.S. Constitution as "our operating system." While there's never been a "golden age" of American Democracy, he added, the perils emerging today are new. "If a Congressman or Senator has to spend five hours a day begging special interests or rich people for money," he said, they'll be more concerned about how what they're saying will appeal to those interests—rather than their constituents. In yet another tangent, Gore railed against genetic engineering, including Spider Goats, which are goats with spliced spider DNA that allows them to secrete spider silk along with their milk. The goats breed, extending that trait to future generations. Gore sees such things as a case of science run amok, alternately creepy and scary."

ananyo writes "The incidence of autoimmune diseases, such as multiple sclerosis and type 1 diabetes, has spiked in developed countries in recent decades. In three studies published today, researchers describe the molecular pathways that can lead to autoimmune disease and identify one possible culprit that has been right under our noses — and on our tables — the entire time: salt. Some forms of autoimmunity have been linked to overproduction of TH17 cells, a type of helper T cell that produces an inflammatory protein called interleukin-17. Now scientists have found sodium chloride turns on the production of these cells (abstract). They also showed that in a mouse model of multiple sclerosis, a high-salt diet accelerated the disease's progression (abstract)."

MTorrice writes "Some biologists would like to train patients' own immune systems to treat diseases such as cancer and autoimmune disorders. They envision isolating a person's immune cells and then programming the cells to destroy tumors or to stop other parts of the immune system from attacking healthy tissue. Now a team of German researchers reports a method that traps immune cells in microscopic water droplets and exposes the cells to chemical signals that could teach them the difference between friend and foe (abstract). The droplets mimic the cellular environments in which immune cells typically trade information about what to attack."

the_newsbeagle writes "This year, a biotech company called Ion Torrent will introduce a new chip for its genome sequencing machine, which should enable researchers and doctors to scan a complete human genome for $1000 and in just a couple of hours. Compare that to the effort required to complete the first human genome: $3 billion and 13 years. Ion Torrent has nearly reached the $1000-genome milestone by virtue of a process called 'semiconductor sequencing,' and the company's founder says his chip-based sequencing machine benefits from all the efficiencies of the computer industry. At a price point of $1000, genome scans could become a routine part of medicine. And the price could keep dropping. To test out the technology, and to investigate just how useful genome scans are these days for your typical, reasonably healthy person, the IEEE Spectrum reporter got her own genome scanned and analyzed."

Velcroman1 writes "Biochemical engineers can now download a piece of software and with a few simple clicks, assemble the DNA for new life forms through their laptops. 'With the proper computer tools, biologists can write their own genetic code — and then turn that code into life,' said biochemist Omri Amirav-Drory, who founded Genome Compiler Corp., the company that sells the software. He demonstrated at a coffee shop early one morning by manipulating a bacteria's genes on his laptop. The synthetic biology app is still in beta; on Jan. 15, the company added an undo feature and support for new DNA file formats. Building creatures is increasingly like word processing, it would seem. But such is the strange reality in the age of cheap genome sequencing, DNA synthesizing and 'bioinformatics.'"

ananyo writes "Monsanto and other biotechnology firms could be looking to bring back 'terminator' seed technology. The seeds are genetically engineered so that crops grown from them produce sterile seed. They prompted such an outcry that, as Slashdot noted, Monsanto's chief executive pledged not to commercialize them. But a case in the U.S. Supreme Court could allow farmers to plant the progeny of GM seeds rather than buying new seeds from Monsanto, making the technology attractive to biotech companies again. Some environmentalists also see 'terminator' seeds as a way of avoiding GM crops contaminating organic/non-GM crops." Reader 9gezegen adds that Monsanto is getting support, oddly, from parts of the software industry. From the NY Times: "BSA/The Software Alliance, which represents companies like Apple and Microsoft, said in a brief that a decision against Monsanto might 'facilitate software piracy on a broad scale' because software can be easily replicated. But it also said that a decision that goes too far the other way could make nuisance software patent infringement lawsuits too easy to file." The case was heard today; here is a transcript (PDF), and a clear explanation of what the case is about.

An anonymous reader writes "In a real life Prisoner's Dilemma taking place in the French city of Marseille, twin brothers have been arrested for a string of sexual assaults. While say they are sure that one of them committed the crimes (corroborated by a standard DNA test), police were told that it would cost upwards of €1m euros (£850,000, $1.3m USD) to distinguish between them using DNA evidence."

Bulldust writes "The Federal Court in Australia has ruled in favor of U.S. biotechnology company Myriad Genetics, enabling them to continue to hold the patent over the so-called breast cancer gene BRCA1. The same patent is also being reconsidered by the U.S. Supreme Court in the current session. From the article: 'Federal court Justice John Nicholas has ruled that a private company can continue to hold a patent over the so-called breast cancer gene BRCA1, in a decision that has devastated cancer victims.The decision is the first in Australia to rule on whether isolated genes can be patented, and will set a precedent in favor of commercial ownership of genetic material.'"

ananyo writes "Synthetic biologists have developed DNA modules that perform logic operations in bacteria. These 'genetic circuits' could, for example, be used by scientists to track key moments in a cell's life or, in biotechnology, to turn on production of a drug at the flick of a chemical switch. The researchers have encoded 16 logic gates in modules of DNA and stored the results of logical operations. The different logic gates can be assembled into a wide variety of circuits."